Related Experiment Video

Updated: Aug 15, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Systemic hypertension associated with cyclosporine: a review

P J Weidle1, P H Vlasses

  • 1Thomas Jefferson University Hospital, Philadelphia, PA 19107.

Drug Intelligence & Clinical Pharmacy
|June 1, 1988
PubMed

Insights

Cyclosporine, an immunosuppressive drug, can cause hypertension, but its effects on blood pressure vary widely. Research is ongoing to understand the causes and treatments for this side effect.

Area of Science:

  • Pharmacology
  • Nephrology
  • Cardiology

Background:

  • The immunosuppressive agent cyclosporine is frequently used in organ transplantation and autoimmune diseases.
  • Cyclosporine use has been linked to an increased incidence of hypertension, a significant clinical concern.

Purpose of the Study:

  • To review the variable reports of cyclosporine-associated hypertension.
  • To identify factors influencing the incidence, onset, duration, and severity of cyclosporine-induced blood pressure elevation.
  • To discuss potential mechanisms and current treatment strategies for cyclosporine-associated hypertension.

Main Methods:

  • Literature review of studies investigating cyclosporine and hypertension.
  • Analysis of factors associated with blood pressure changes in patients using cyclosporine.
  • Synthesis of information on proposed pathophysiological mechanisms.
  • Overview of therapeutic interventions for managing cyclosporine-induced hypertension.

Main Results:

  • The incidence, onset, duration, and severity of hypertension vary significantly among patients treated with cyclosporine.
  • Therapeutic indication for cyclosporine use appears to be a key factor influencing blood pressure elevation.
  • Several factors have been evaluated for their association with cyclosporine-induced hypertension, but results are often disparate.

Conclusions:

  • Cyclosporine-associated hypertension is a complex issue with considerable variability in presentation and influencing factors.
  • Further research is essential to elucidate the precise mechanisms and identify optimal treatment approaches.
  • Clarification of conflicting information is needed for effective patient management.

More Related Videos

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...